期刊文献+

组蛋白去乙酰化酶抑制剂研究进展 被引量:3

Research progress of histone deacetylase inhibitors
原文传递
导出
摘要 组蛋白去乙酰化酶是一种应用广泛且能够在多种肿瘤组织细胞中实现高表达的酶家族,这种酶会直接影响到肿瘤的发生过程以及发展过程,被认为一种能够治疗肿瘤的有效靶点。因此,研究开发新型的组蛋白去乙酰化酶抑制剂对肿瘤疾病的治疗具有重要的意义。近年来,关于组蛋白去乙酰化酶抑制剂的研究与开发取得了快速的发展。综述了组蛋白去乙酰化酶抑制剂的作用,并分类介绍其研究进展,期望对组蛋白去乙酰化酶抑制剂的研究与开发提供参考。 Histone deacetylase is a widely used enzyme family which can be overexpressed in many kinds of tumor tissues and cells,it is considered an effective target to treat tumor.Therefore,the research and development of new histone deacetylase inhibitors for the treatment of tumor diseases is of great significance.In recent years,the research and development of histone deacetylase inhibitors have made rapid progress.In this paper,the function of histone deacetylase inhibitors was briefly reviewed,and its research progress was introduced.It was expected to provide reference for the research and development of histone deacetylase inhibitors.
作者 杜漠 赵梅梅 高艳蓉 仝红娟 DU Mo;ZHAO Mei-mei;GAO Yan-rong;TONG Hong-juan(School of Pharmacy,Shaanxi Institute of International Trade&Commerce,Xi'an 712046,China;Collaborative Innovation Center of Green Manufacturing Technology for Traditional Chinese Medicine in Shaanxi Province,Xi’an 712046,China)
出处 《精细与专用化学品》 CAS 2022年第1期46-50,共5页 Fine and Specialty Chemicals
基金 陕西省大学生创新创业训练计划资助项目(S202013123049) 陕西国际商贸学院校级资助项目(SMXY202123)。
关键词 组蛋白去乙酰化酶 组蛋白去乙酰化酶抑制剂 分类 进展 histone deacetylase histone deacetylase inhibitors classification progress
  • 相关文献

参考文献7

二级参考文献52

  • 1Yuyin LV,Chunsheng YIN,Hongyan LIU,Zhongsheng YI,Yang WANG.3D-QSAR study on atmospheric half-lives of POPs using CoMFA and CoMSIA[J].Journal of Environmental Sciences,2008,20(12):1433-1438. 被引量:7
  • 2Pennisi, E. Science 1997, 275, 155.
  • 3Marks, P. A.; Rifkind, R. A.; Richon, V. M.; Breslow, R. R.; Miller, T.; Kelly, W. K. Nat. Rev. Cancer 2001, 1, 194.
  • 4Biel, M.; Wascholowski, V.; Giannis, A. Angew. Chem., lnt. Ed. 2005, 44, 3186.
  • 5Frew, A. J.; Johnstone, R. W.; Bolden, J. E. Cancer Lett. 2009, 280, 125.
  • 6Jones, P.; Altamura, S.; Chakravarty, P. C.; Cecchetti, O.; Francesco, R. D.; Gallinari, P.; Ingenito, R.; Meinke, P. T.; Petrocchi, A.; Rowley, M.; Scarpelli, R.; Serafini, S.; Steinkuhler, C. Bioorg. Med. Chem. Left. 2006, 16, 5948.
  • 7Botrugno, O. A.; Santoro, F.; Minucci, S. Cancer Lett. 2009, 280, 134.
  • 8De Shepper, S.; Bruwiere, H.; Verhulst, T.; Steller, U.; Andries, L.; Wouters, W.; Janicot, M.; Arts, J.; Van Heusden, J. J. Pharmacol. Exp. Ther. 2003, 304(2), 881.
  • 9Ueda, H.; Nakajima, H.; Hori, Y.; Fujita, T.; Nishimura, M.; Goto, T.; Okuhara, M. J. Antibiot. 1994, 47(3), 301.
  • 10Li, K. W.; Wu, J.; Xing W.; Simon, J. A. J. Am. Chem. Soc. 1996, 118(30), 7237.

共引文献17

同被引文献49

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部